share_log

Why Health Catalyst, Inc. (NASDAQ:HCAT) Could Be Worth Watching

Why Health Catalyst, Inc. (NASDAQ:HCAT) Could Be Worth Watching

爲什麼 Health Catalyst, Inc.(納斯達克股票代碼:HCAT)值得關注
Simply Wall St ·  01/27 07:33

Health Catalyst, Inc. (NASDAQ:HCAT), is not the largest company out there, but it led the NASDAQGS gainers with a relatively large price hike in the past couple of weeks. While good news for shareholders, the company has traded much higher in the past year. With many analysts covering the stock, we may expect any price-sensitive announcements have already been factored into the stock's share price. However, could the stock still be trading at a relatively cheap price? Let's examine Health Catalyst's valuation and outlook in more detail to determine if there's still a bargain opportunity.

Health Catalyst, Inc.(納斯達克股票代碼:HCAT)並不是目前最大的公司,但在過去的幾週中,它以相對較大的價格上漲帶領納斯達克股價上漲。儘管對股東來說是個好消息,但該公司的交易量在過去一年中大幅上漲。由於許多分析師都在報道該股,我們可能預計,任何對價格敏感的公告都已計入該股的股價。但是,該股票還能以相對便宜的價格交易嗎?讓我們更詳細地研究一下Health Catalyst的估值和前景,以確定是否還有討價還價的機會。

View our latest analysis for Health Catalyst

查看我們對健康催化劑的最新分析

What Is Health Catalyst Worth?

健康催化劑的價值是什麼?

Good news, investors! Health Catalyst is still a bargain right now. According to our valuation, the intrinsic value for the stock is $14.60, but it is currently trading at US$10.30 on the share market, meaning that there is still an opportunity to buy now. Although, there may be another chance to buy again in the future. This is because Health Catalyst's beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, the company's shares will likely fall by more than the rest of the market, providing a prime buying opportunity.

好消息,投資者!Health Catalyst 現在仍然很划算。根據我們的估值,該股票的內在價值爲14.60美元,但目前在股票市場上的交易價格爲10.30美元,這意味着現在仍有機會買入。但是,將來可能會有另一次買入的機會。這是因爲Health Catalyst的貝塔值(衡量股價波動的指標)很高,這意味着其價格相對於其他市場的價格走勢將被誇大。如果市場看跌,該公司的股票下跌幅度可能會超過其他市場,這提供了絕佳的買入機會。

What kind of growth will Health Catalyst generate?

健康催化劑會帶來什麼樣的增長?

earnings-and-revenue-growth
NasdaqGS:HCAT Earnings and Revenue Growth January 27th 2024
納斯達克GS:HCAT 收益和收入增長 2024 年 1 月 27 日

Future outlook is an important aspect when you're looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Although value investors would argue that it's the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. Health Catalyst's earnings over the next few years are expected to increase by 52%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.

當你考慮買入股票時,未來前景是一個重要的方面,特別是如果你是尋求投資組合增長的投資者。儘管價值投資者會爭辯說,最重要的是相對於價格的內在價值,但更有說服力的投資論點是以低廉的價格獲得高增長潛力。Health Catalyst在未來幾年的收益預計將增長52%,這表明未來的前景非常樂觀。這應該會帶來更強勁的現金流,從而提高股票價值。

What This Means For You

這對你意味着什麼

Are you a shareholder? Since HCAT is currently undervalued, it may be a great time to accumulate more of your holdings in the stock. With an optimistic outlook on the horizon, it seems like this growth has not yet been fully factored into the share price. However, there are also other factors such as financial health to consider, which could explain the current undervaluation.

你是股東嗎?由於HCAT目前的估值被低估,因此現在可能是積累更多股票的好時機。隨着樂觀前景的臨近,這種增長似乎尚未完全納入股價。但是,還有其他因素需要考慮,例如財務狀況,這可以解釋當前低估的原因。

Are you a potential investor? If you've been keeping an eye on HCAT for a while, now might be the time to make a leap. Its prosperous future outlook isn't fully reflected in the current share price yet, which means it's not too late to buy HCAT. But before you make any investment decisions, consider other factors such as the strength of its balance sheet, in order to make a well-informed investment decision.

你是潛在的投資者嗎?如果您關注 HCAT 已有一段時間了,那麼現在可能是實現飛躍的時候了。其繁榮的未來前景尚未完全反映在當前的股價中,這意味着現在購買HCAT還爲時不晚。但是,在做出任何投資決策之前,請考慮其他因素,例如資產負債表的強度,以便做出明智的投資決策。

If you'd like to know more about Health Catalyst as a business, it's important to be aware of any risks it's facing. While conducting our analysis, we found that Health Catalyst has 2 warning signs and it would be unwise to ignore these.

如果您想進一步了解Health Catalyst作爲一家企業,請務必了解其面臨的任何風險。在進行分析時,我們發現Health Catalyst有兩個警告信號,忽視這些信號是不明智的。

If you are no longer interested in Health Catalyst, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

如果您不再對Health Catalyst感興趣,可以使用我們的免費平台查看我們列出的其他50多隻具有高增長潛力的股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論